Cipla issues clarification with regards to stake sale by the Promoters
Ms. Samina Hamied, Executive Vice Chairperson, Cipla issued below statement with regards to sale of 2,01,69,756 ...
Read moreMs. Samina Hamied, Executive Vice Chairperson, Cipla issued below statement with regards to sale of 2,01,69,756 ...
Read moreCasirivimab and Imdevimab is indicated for restricted use in emergency situation for the treatment of mild ...
Read moreCipla Limited today announced the commercialisation of a polymerase chain reaction (RT-PCR) test kit ‘ViraGen’ for ...
Read moreCipla Limited today announced it has signed a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly ...
Read moreCasirivimab and Imdevimab is indicated for the treatment of mild to moderate Covid-19 in high-risk patients ...
Read moreAlkem Laboratories Limited & Cipla Limited has entered into an agreement to become a partner in ...
Read moreCipla announced Re-appointment of Mr. Umang Vohra as Managing Director and Global Chief Executive Officer of the ...
Read moreCipla Therapeutics, a divison of Cipla USA, Inc., an affiliate of Cipla Limited and SIGA Technologies, ...
Read moreAddress: | Pharma Reg News, First floor, Shop no.1 , Plot no 241,242, Near Fire station, GIDC, Ankleshwar, Gujarat - 393002. |
Phone: | +91 8511586232, +91 9029066605 |
Email: | author@pharmaregnews.com |
© 2021 - Pharmaregnews.com. Developed by YESWEUS.
© 2021 - Pharmaregnews.com. Developed by YESWEUS.